egfr in metastatic colon cancer
Published 8 years ago • 140 plays • Length 4:15Download video MP4
Download video MP3
Similar videos
-
7:42
egfr-targeted therapy in metastatic colorectal cancer
-
2:10
anti-egfr therapy for ras wild-type left-sided colorectal cancer
-
1:12
targeted therapies in metastatic colorectal cancer
-
0:42
dr. fakih on anti-angiogenesis versus anti-egfr therapy in colon cancer
-
1:33
acquired resistance to anti-egfr therapy in colorectal cancer
-
7:10
upfront egfr therapy in metastatic colorectal cancer
-
7:32
considerations when selecting an egfr inhibitor in metastatic colorectal cancer
-
5:09
egfr therapy as upfront colorectal cancer treatment
-
2:14
anti-egfr rechallenge therapy with or without trametinib in addition to panitumumab in advanced crc
-
8:20
debate: first line egfr therapy for left sided ras/braf wt metastatic colon cancer? - yes
-
16:56
colorectal cancer with acquired resistance to egfr antibodies: how to manage?
-
4:16
aacr 2009: genetic influences in response to egfr for metastatic colorectal cancer
-
4:56
upfront bevacizumab and cetuximab compared in metastatic colorectal cancer
-
17:17
debate: targeted therapy for ras/braf wt left sided colon cancers - egfr antibodies are mandatory
-
10:09
treatment of metastatic colon cancer - sarah cannon
-
11:54
debate: targeted therapy for ras/braf wt left sided colon cancers - bevacizumab or egfr antibodies
-
9:00
first- and later-line use of panitumumab in metastatic colorectal cancer
-
13:46
choosing between anti-vegf and anti-egfr targeted therapy
-
6:19
clinical development of cetuximab in metastatic colorectal cancer